SB
GERN icon

Samsara BioCapital’s Geron GERN Stock Holding History

Samsara BioCapital’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,224,870
Closed -$1.95K – 47
2020
Q4 		$1.95K Sell
1,224,870
-306,218
-20% -$558K 0.2% 35
2020
Q3 		$2.66M Sell
1,531,088
-2,359,132
-61% -$4.36M 0.74% 23
2020
Q2 		$8.48M Buy
+3,890,220
New +$5.82M 2.73% 12

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Samsara BioCapital's GERN Position: Q1 2021 in Review

Samsara BioCapital sold out of Geron (GERN) in Q1 2021, closing a stake of 1,224,870 shares — an estimated $1.95K sold.

Samsara BioCapital first reported a position in GERN in Q2 2020 and held it in 3 quarters. The position peaked at $8.48M in Q2 2020. 146 funds tracked by Wall St. Rank hold GERN as of Q1 2021.

  • Samsara BioCapital reported no remaining Geron position as of Q1 2021 after selling out during the quarter.
  • Samsara BioCapital sold 1,224,870 Geron shares in Q1 2021, an estimated $1.95K.
  • Samsara BioCapital first reported a position in Geron in Q2 2020 and held it in 3 quarters.
  • Samsara BioCapital's Geron position peaked at $8.48M in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Geron as of Q1 2021.

Based on Samsara BioCapital's 13F filing for Q1 2021, filed 18 May 2021.